Literature DB >> 31482246

Steroid pulse therapy of radiological disease activity without clinical relapse in CLIPPERS.

Takashi Hosaka1, Kiyotaka Nakamagoe2, Naoki Tozaka1, Satoshi Aizawa1, Akira Tamaoka1.   

Abstract

Entities:  

Year:  2019        PMID： 31482246     DOI： 10.1007/s10072-019-04064-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors:  Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

Review 2.  Therapeutic Approaches in CLIPPERS.

Authors:  Guillaume Taieb; Thibaut Allou; Pierre Labauge
Journal:  Curr Treat Options Neurol       Date:  2017-05       Impact factor: 3.598

3.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Authors:  Sean J Pittock; Jan Debruyne; Karl N Krecke; Caterina Giannini; Jelle van den Ameele; Veerle De Herdt; Andrew McKeon; Robert D Fealey; Brian G Weinshenker; Allen J Aksamit; Bruce R Krueger; Elizabeth A Shuster; B Mark Keegan
Journal:  Brain       Date:  2010-07-17       Impact factor: 13.501

Review 4.  CLIPPERS.

Authors:  Nicholas L Zalewski; W Oliver Tobin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

5.  Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Authors:  W Oliver Tobin; Yong Guo; Karl N Krecke; Joseph E Parisi; Claudia F Lucchinetti; Sean J Pittock; Jay Mandrekar; Divyanshu Dubey; Jan Debruyne; B Mark Keegan
Journal:  Brain       Date:  2017-09-01       Impact factor: 13.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.